Go to main page

SYMPOSIUM: Innovative Approaches to Accelerating Drug Discovery and Development (San Francisco, CA)

Request Presentation Slides

From Small Fragments to Big Drugs: Fragment-based Drug Discovery

Dan Erlanson, Ph.D | Co-founder and VP of Chemistry | Carmot Therapeutics

From Fragments to Drugs: Playing Quick Molecular Scrabble with Protein Crystallography

Debanu Das, Ph.D | Co-founder and CEO | Accelero Biostructures

Role of DMPK in Drug Discovery and Development

JP Shaw, Ph.D | Independent Pre-Clinical DMPK Consultant

Paving the Road to the Clinic: Advancing Oncology Drug Development with Translational In Vitro and In Vivo Models

Tommy Broudy, Ph.D | CEO | Molecular Response

BioDuro Solution Engine: Enabled Formulations Bridging Discovery and Development

Blair West, Ph.D | Chief Science Officer, Global CMC Solutions | BioDuro

Rapid Development and Scale-up of Solubilized Dosage Forms

Ruchit Trivedi, Ph.D | Associate Director, Formulation | BioDuro

Interested in a presentation?
Request a copy using the form below.


How can we accelerate successful drug discovery and development?

The success of clinical candidate development depends on several factors, important among them are generation of novel, therapeutically-relevant chemical structures, early and rapid assessment of possible efficacy of candidate structures in pre-clinical therapeutic models and rapid elimination of candidates that will ultimately prove unsuccessful. Innovative processes and techniques that facilitate optimal candidate selection is a crucial step in accelerating drug discovery and development timelines.


Thursday, March 22, 2018
11:30 AM – 6:30 PM PDT


Hilton Garden Inn San Francisco Airport North
670 Gateway Blvd
South San Francisco, CA 94080


11:30 PM- 12:30 PM

12:30 PM- 5:15 PM

Networking Happy Hour
5:15 PM- 6:30 PM